What is LTGO's current stock price?

LTGO (Latigo Biotherapeutics Inc.) is currently trading at $18.25 with a market cap of $1.10B.

What sector is Latigo Biotherapeutics Inc. in?

Latigo Biotherapeutics Inc. (LTGO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.

InvestLog

Back to Market返回行情

LTGO Latigo Biotherapeutics Inc.

NASDAQHealthcare

$18.25+1.39%ClosedMarket Cap: $1.10B

As of 2026-08-07

Why LTGO matters now

Latigo Biotherapeutics Inc. (LTGO) is a US stock in Healthcare. The latest InvestLog snapshot shows $18.25 with +1.39% on the session and $1.10B in market capitalization.

The latest indexable market news headline is "Latigo Biotherapeutics Announces New England Journal of Medicine Publication of Positive LTG-001 Abdominoplasty Clinical Trial Results in Moderate-to-Severe Acute Pain" from Business Wire.

Latest News

Latigo Biotherapeutics Announces New England Journal of Medicine Publication of Positive LTG-001 Abdominoplasty Clinical Trial Results in Moderate-to-Severe Acute PainBusiness Wire · 2026-07-29

Company Info

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

Exchange

NASDAQ

Beta

0.00

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.